Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response.
Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Scope of the Report:
The global average price of Prostaglandin is in the decreasing trend, from 361.6 USD/Kg in 2012 to 331.1 USD/L in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Prostaglandin includes Human Prostaglandin and Veterinary Prostaglandin. The proportion of Human Prostaglandin in 2016 is about 82%, and the proportion is in decreasing trend from 2012 to 2016.
Prostaglandin is widely used in Cardiovascular, Digestive, Gynecological and Obstetrical, Ophthalmologic, etc. The most proportion of Prostaglandin is Cardiovascular, and the sales in 2016 is about 410 Kg.
The worldwide market for Prostaglandin is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 660 million US$ in 2024, from 460 million US$ in 2019, according to a new WMR study.
This report focuses on the Prostaglandin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Yonsung Fine Chemicals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Gynecological and Obstetrical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostaglandin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostaglandin, with price, sales, revenue and global market share of Prostaglandin in 2017 and 2018.
Chapter 3, the Prostaglandin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostaglandin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Prostaglandin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Prostaglandin sales channel, distributors, customers, research findings and conclusion, appendix and data source.